SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Oxoid IDEIA Viral Gastroenteritis Panel allows rapid diagnosis of Norovirus and other leading causes of viral gastroenteritis

Thermo Fisher Scientific
18 Jan 2008

Product news

Oxoid, a world leader in microbiology, has launched the IDEIA™ range of products for the rapid diagnosis of viral gastroenteritis. These rapid enzyme immunoassays can be used to detect the four leading causes of viral gastroenteritis: Norovirus, Rotavirus, Astrovirus and Adenovirus, in human stool samples.

There has recently been an increase in norovirus activity throughout Europe1,2, making the rapid detection of this virus of particular concern. Timely identification of the etiological agent combined with appropriate infection control procedures can help to reduce the impact of norovirus outbreaks on the institution involved3. IDEIA Norovirus allows norovirus to be detected in stool samples within just 2 hours.

Barbara Fallowfield, marketing manager, Oxoid (Ely) commented, “The sooner the cause of gastroenteritis outbreaks can be detected, the sooner infection control procedures can be put in place to stop the spread of disease and limit the damage. IDEIA Norovirus provides rapid and reliable results that are of enormous value to those involved in the investigation and prevention of norovirus outbreaks, including microbiology laboratories, infection control teams, surveillance teams and cruise ship operators.”

Each IDEIA viral gastroenteritis kit follows the same standardised protocol and is suitable for manual or automated testing. The assays are quick and easy to perform, either individually or in a panel using a single sample dilution. Sensitive and specific results are read photometrically in less than 2 hours.

For further information about the IDEIA Viral Gastroenteritis Panel (IDEIA Norovirus, IDEIA Rotavirus, IDEIA Astrovirus (Amplified) or IDEIA Adenovirus), please contact Oxoid.

Oxoid is part of Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science.

References:
1. Food-borne Viruses in Europe Network (FBVE), (2006) Eurosurveillance Weekly 11(12).
2. Takkinen, J. (2006) Eurosurveillance Weekly 11(6).
3. Lopman, B.A., Reaches, M.H., Vipond, I.B. et al (2004) Emerg. Infect. Dis. 10(10):1827-1834

Links

Thermo Fisher ScientificCompany website

Tags

MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.

Related articles